PELIZZARI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 1.266
EU - Europa 216
AS - Asia 204
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.690
Nazione #
US - Stati Uniti d'America 1.263
SG - Singapore 95
IT - Italia 59
CN - Cina 58
DE - Germania 29
VN - Vietnam 29
BE - Belgio 24
UA - Ucraina 22
IE - Irlanda 21
RU - Federazione Russa 18
IN - India 15
FI - Finlandia 13
GB - Regno Unito 13
IR - Iran 7
CZ - Repubblica Ceca 6
CA - Canada 3
LT - Lituania 3
EG - Egitto 2
RO - Romania 2
SE - Svezia 2
BY - Bielorussia 1
CL - Cile 1
EU - Europa 1
FR - Francia 1
NL - Olanda 1
NO - Norvegia 1
Totale 1.690
Città #
Chandler 172
Fairfield 134
Ashburn 123
Ann Arbor 111
Singapore 92
Seattle 64
Houston 58
Woodbridge 50
Wilmington 49
Cambridge 41
New York 34
Boardman 32
Dong Ket 29
Beijing 27
Princeton 26
Brussels 24
Dublin 21
San Diego 15
Redmond 14
Dearborn 13
Helsinki 13
Jacksonville 12
Ogden 11
Martignacco 9
Munich 8
Washington 8
Leawood 7
Ardabil 6
Dallas 6
Brno 5
Augusta 4
Des Moines 4
Jinan 4
Los Angeles 4
San Mateo 4
Santa Clara 4
Trieste 4
Udine 4
Caserta 3
London 3
Nanjing 3
Norwalk 3
Scafati 3
Toronto 3
Cairo 2
Chongqing 2
Clifton 2
Edinburgh 2
Frankfurt am Main 2
Hyderabad 2
Milan 2
Nanning 2
Phoenix 2
Redwood City 2
Sagrado 2
Asti 1
Bangalore 1
Baoding 1
Boston 1
Bucharest 1
Chengdu 1
Florence 1
Fuzhou 1
Grafing 1
Harbin 1
Jiaxing 1
Kunming 1
Langfang 1
Melfi 1
Mortegliano 1
Nanchang 1
Nantong 1
Naples 1
Paris 1
Prague 1
Romans 1
Rutigliano 1
San Francisco 1
San Remo 1
Shenyang 1
Shenzhen 1
Trento 1
Tuenno 1
Venezia 1
Wenzhou 1
Wuhan 1
Zibo 1
Totale 1.318
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 123
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 112
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 104
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 103
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 95
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 92
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 92
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 84
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 83
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 83
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 71
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 69
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 67
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 65
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 60
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 52
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 52
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 51
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 45
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 44
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 43
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 40
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 37
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 37
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 34
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 33
Totale 1.771
Categoria #
all - tutte 8.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020275 0 0 0 0 0 26 24 38 79 57 37 14
2020/2021423 24 28 59 46 36 8 19 49 13 28 53 60
2021/2022261 22 28 0 5 6 3 17 16 2 34 102 26
2022/2023336 32 49 5 42 39 68 1 27 44 5 16 8
2023/2024205 19 7 9 8 38 79 0 5 15 4 1 20
2024/2025201 14 32 23 48 54 30 0 0 0 0 0 0
Totale 1.771